Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 15, 2024
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
[ Wed, May 15th 2024
] - WOPRAI
Tue, May 14, 2024
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
[ Tue, May 14th 2024
] - WOPRAI
Andrew Fein Reiterated (TCRX) at Strong Buy and Held Target at $15 on, May 14th, 2024
Andrew Fein of HC Wainwright & Co., Reiterated "TScan Therapeutics, Inc." (TCRX) at Strong Buy and Held Target at $15 on, May 14th, 2024.
Andrew has made no other calls on TCRX in the last 4 months.
There are 3 other peers that have a rating on TCRX. Out of the 3 peers that are also analyzing TCRX, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Andrew
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $11 on, Monday, May 13th, 2024
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $10 on, Tuesday, April 23rd, 2024
- Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $9 on, Thursday, March 7th, 2024
